Masimo Corporation is a global medical technology company dedicated to improving patient outcomes and reducing the cost of care through innovative noninvasive monitoring technologies. The company's mission is to enhance the quality of patient care by providing advanced monitoring solutions that deliver accurate and reliable data. Masimo's strategy focuses on continuous innovation and expanding its product offerings, including pulse oximetry and other noninvasive monitoring devices, to meet the evolving needs of healthcare providers. Through its commitment to research and development, Masimo aims to lead the market in noninvasive monitoring and improve clinical decision-making worldwide.

MASIMO CORP

Masimo (MASI) is gearing up to release its fourth-quarter fiscal 2024 results on February 25, showcasing a Zacks Rank of #1 (Strong Buy) and an impressive Earnings Surprise Prediction (ESP) of +4.05%. This comes on the heels of a robust performance over the past year, during which the company has...

Masimo Expected to Outperform Earnings Estimates with 14.4% EPS Growth in Upcoming Q4 2024 Results

As Masimo prepares to unveil its Q4 2024 results, expectations are high with a projected 14.4% EPS growth and a strong track record of exceeding estimates. Can this innovative leader in medical devices continue its upward momentum amidst a competitive landscape?